AT185072T - Pharmaceutical preparations for contraception / hormone replacement with biogenic estrogen - Google Patents

Pharmaceutical preparations for contraception / hormone replacement with biogenic estrogen

Info

Publication number
AT185072T
AT185072T AT95250153T AT95250153T AT185072T AT 185072 T AT185072 T AT 185072T AT 95250153 T AT95250153 T AT 95250153T AT 95250153 T AT95250153 T AT 95250153T AT 185072 T AT185072 T AT 185072T
Authority
AT
Austria
Prior art keywords
contraception
pharmaceutical preparations
hormone replacement
biogenic estrogen
biogenic
Prior art date
Application number
AT95250153T
Other languages
German (de)
Inventor
Michael Prof Dr Oettel
Herman Dr Osterwald
Claudia Dr Moore
Thomas Dr Graeser
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE19944429374 priority Critical patent/DE4429374C1/en
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of AT185072T publication Critical patent/AT185072T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/841Contraceptive
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00Drug, bio-affecting and body treating compositions
    • Y10S514/841Contraceptive
    • Y10S514/843Female mammal
AT95250153T 1994-08-12 1995-06-28 Pharmaceutical preparations for contraception / hormone replacement with biogenic estrogen AT185072T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19944429374 DE4429374C1 (en) 1994-08-12 1994-08-12 Pharmaceutical preparations for contraception / hormone replacement with biogenic estrogen

Publications (1)

Publication Number Publication Date
AT185072T true AT185072T (en) 1999-10-15

Family

ID=6526045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95250153T AT185072T (en) 1994-08-12 1995-06-28 Pharmaceutical preparations for contraception / hormone replacement with biogenic estrogen

Country Status (5)

Country Link
US (1) US5633242A (en)
EP (1) EP0696454B1 (en)
JP (1) JP3002117B2 (en)
AT (1) AT185072T (en)
DE (1) DE4429374C1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19513662A1 (en) * 1995-04-08 1996-10-10 Schering Ag The pharmaceutical combination product for hormonal contraception
US6225299B1 (en) * 1996-09-16 2001-05-01 Jenapharm Gmbh & Co. Kg Hormonal agent for skin treatment
US20050032756A1 (en) * 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
DE19540253C2 (en) 1995-10-28 1998-06-04 Jenapharm Gmbh Multiphase product for contraception based on natural estrogens
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
US6451778B1 (en) 1996-07-26 2002-09-17 Wyeth Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
AU713016B2 (en) * 1996-07-26 1999-11-18 Wyeth Oral contraceptive
US6479475B1 (en) 1996-07-26 2002-11-12 Wyeth Oral contraceptive
FR2775599B1 (en) * 1998-03-09 2001-08-17 Besins Iscovesco Lab A pharmaceutical composition based on natural synthetic progesterone and estradiol and its method of preparing
DE19834931A1 (en) * 1998-07-28 2000-02-24 Jenapharm Gmbh Use of biogenic estrogens for hormone replacement therapy
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
DK1214076T3 (en) * 1999-08-31 2004-02-23 Schering Ag A pharmaceutical combination of drospirenone and ethinylestradiol for use as a contraceptive agent
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
EP1361881B1 (en) * 2000-12-14 2005-10-26 Ortho-Mcneil Pharmaceutical, Inc. Steroid hormone products and methods for preparing them
EP1260225A1 (en) * 2001-05-18 2002-11-27 Pantarhei Bioscience B.V. A pharmaceutical composition for use in hormone replacement therapy
CA2447178C (en) * 2001-05-18 2010-06-08 Christian Franz Holinka Pharmaceutical composition for use in hormone replacement therapy
EP1390043A1 (en) * 2001-05-23 2004-02-25 Pantarhei Bioscience B.V. Means and method for hormonal contraception
CA2448273C (en) * 2001-05-23 2010-06-29 Christian Franz Holinka Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
ES2296943T3 (en) * 2001-05-23 2008-05-01 Pantarhei Bioscience B.V. System administration of an estrogen drug tetrahydroxy intended for hormonal contraception.
AT254465T (en) * 2001-05-23 2003-12-15 Pantarhei Bioscience Bv Preparations for hormonal contraception
ES2375105T3 (en) * 2001-06-18 2012-02-24 Noven Pharmaceuticals, Inc. enhanced drug in transdermal administration systems.
PT1446128E (en) * 2001-11-15 2007-03-30 Pantarhei Bioscience Bv Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
AU2002348272B2 (en) * 2001-12-05 2008-07-31 Theramex HQ UK Limited Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
CA2489270C (en) * 2002-06-11 2012-08-07 Pantarhei Bioscience B.V. A method of treating human skin and a skin care composition for use in such a method
PT1511496E (en) * 2002-06-11 2007-01-31 Pantarhei Bioscience Bv Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
AU2003253506A1 (en) 2002-07-12 2004-02-02 Pantarhei Biosciences B.V. Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
PT1556058E (en) 2002-10-23 2008-03-20 Pantarhei Bioscience Bv Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
NZ574964A (en) * 2003-07-16 2011-10-28 Teva Womens Health Inc Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102004019743B4 (en) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Multiphase product for contraception based on a natural estrogen
WO2006013464A1 (en) * 2004-07-27 2006-02-09 Amistad Pharma Sas Hormone replacement therapy comprising a combination of 17-beta-oestradiol and chlormadinone acetate
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
ES2322479T3 (en) * 2005-10-13 2009-06-22 Bayer Schering Pharma Aktiengesellschaft Use of estradiol valerate in combination with dienogest for oral therapy of dysfunctional uterine bleeding, in conjunction with an oral contraception.
AT546144T (en) * 2005-10-13 2012-03-15 Bayer Pharma AG Use of estradiol valerate in combination with dienogest for oral therapy of DYSF unktionellen uterine bleeding in unit with oral contraception
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (en) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Application of estradiol valerate or 17ß-estradiol in combination with dienogest for oral therapy to maintain and/or increase the female libido
AT473746T (en) * 2007-01-08 2010-07-15 Pantarhei Bioscience Bv A method for treatment or prevention of infertility in female mammals and pharmaceutical kit for use of this method
MX2014015900A (en) 2012-06-18 2015-07-17 Therapeuticsmd Inc Progesterone formulations.
EP2782584A4 (en) 2011-11-23 2015-12-23 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150133421A1 (en) 2012-11-21 2015-05-14 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
KR20180126582A (en) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 Steroid hormone pharmaceutical compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
DE2645307C2 (en) * 1976-10-05 1988-10-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
DE4104385C1 (en) 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4224534A1 (en) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulation-inhibiting agent for hormonal contraception
DE4308406C1 (en) * 1993-03-12 1994-06-16 Jenapharm Gmbh Contraceptive compsn. with reduced hormone dose and reduced side-effects - contg. synergistic mixt. of biogenic, synthetic oestrogen and gestagen
DE4313926A1 (en) * 1993-04-28 1994-11-03 Jenapharm Gmbh Multiphase pharmaceutical product for hormonal contraception
DE4344405C2 (en) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulation-inhibiting agent for hormonal contraception and methods

Also Published As

Publication number Publication date
JPH08169833A (en) 1996-07-02
EP0696454A3 (en) 1996-07-17
EP0696454A2 (en) 1996-02-14
EP0696454B1 (en) 1999-09-29
US5633242A (en) 1997-05-27
DE4429374C1 (en) 1996-02-01
JP3002117B2 (en) 2000-01-24

Similar Documents

Publication Publication Date Title
DK1166743T3 (en) Medicament for reconstitution indspröjteligt
DE69718495T2 (en) A system for drug delivery by transport
DK0792289T3 (en) Small molecule peptidomimetic growth hormone secretagogues
DE69331906D1 (en) Granulated pharmaceutical composition
NL300210I2 (en) Human growth hormone variant.
NO974736A (en) Tilmalt dose inhaler for salmeterol
DE69635993T8 (en) Jellied medical composition for oral administration
NO970507D0 (en) Composition for delivering drugs through the mucosa
DE69534163D1 (en) Polymer particles for drug delivery
NO984038D0 (en) Multiple unit dosage material modified release
BR9408377A (en) Compound procedure pharmaceutical composition for stimulating the release of growth hormone from the pituitary, and use of the compound
DE69620257T2 (en) Drug delivery device with cartouche
AT108676T (en) Device for administration of powdered medicinal substances.
DE68902954T2 (en) Aqueous ueberzugsemulsion for pharmaceutical dosage forms.
DE59107402D1 (en) Preparation for drug delivery in the form of micro-droplets
FR2740686B1 (en) stable lyophilized pharmaceutical formulation
DE69518839T2 (en) Multilayer pharmaceutical dosage form with controlled release
RU2002109746A (en) Fenofibratnaya pharmaceutical composition having high biological potential, and a process for its preparation
RU99118175A (en) Fenofibratnaya pharmaceutical composition having high biological potential, and a process for its preparation
DE69529844D1 (en) New quinuclidine derivatives and pharmaceutical compositions containing them
DE69717092D1 (en) Use of a pharmaceutical composition containing a peptide appetitzügelndes
RU97112170A (en) Filling device for needleless injector container
DE29723499U1 (en) Pacifier for delivering medicine
DE69330547T2 (en) Preparation with drug delivery verzörgerter
TR199500878A2 (en) The pharmaceutical formulations of fluoxetine.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee